Building on the O-glycomic landscape of bladder tumours, where GLUT1-positive tumour areas co-localized with ST and STn aberrant glycosylation, a guided downstream glycoprotein annotation by mass spectrometry was employed. This evidence concerns the gene SLC2A1 and urinary bladder neoplasm.